Very importantly, in research, just one component of a very large portfolio of research support is delivered through the Canadian Institutes of Health Research. In that case, those funds would be allocated based on scientific peer review. They would be assessing a range of proposals and obviously making recommendations for funding. That's not the direct responsibility of our department.
In terms of funding from the strategic innovation fund, for example the funding that's been announced for vaccines and therapies, at the moment we are establishing scientific industry advisory bodies to provide advice to the department on the best opportunities to pursue. That is ongoing. It's important that we establish strong merit in choosing which projects will advance so they withstand scrutiny and deliver the results and outcomes that Canadians expect.